School of Medicine
Showing 51-100 of 181 Results
-
Andrew Martin
Information Systems Specialist, Med/Quantitative Sciences Unit
Current Role at StanfordIn my role as Biomedical Data Management Solutions Lead I oversee a team of talented software engineers and application specialists who enable clinical research and discovery at Stanford. As a part of Technology and Digital Solutions, our larger Research IT team works both with the Stanford School of Medicine, Stanford Children's Hospital, and Stanford Hospital and Clinics to design, build, and support critical research applications and tools. I provide consultations with faculty to discuss research plans and provide insight for applying technology to data collection, monitoring, and participant reported measures.
-
Ashley Martinez, MD, MAS
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Ashley Martinez is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
Dr. Martinez specializes in caring for kidney transplant recipients. She has expertise in pre-transplant evaluation and readiness, immunosuppression, kidney allograft survival, and the prevention and treatment of post-transplant complications. She prioritizes clear, personalized communication at every point to improve care.
Dr. Martinez earned her medical degree from Harvard Medical School and completed her residency in internal medicine at Massachusetts General Hospital. She completed clinical and research fellowships in nephrology at the University of California, San Francisco (UCSF), where she also earned a master’s degree in clinical research. She completed her transplant nephrology fellowship at Stanford University School of Medicine.
Dr. Martinez’s research interests focus on addressing the needs of patients impacted by language barriers. Her work has emphasized the need to improve provider-patient communication, patient education, and evaluation tools for patients with limited English proficiency. She aims to increase awareness of communication gaps and increase patient-centered communication throughout the course of kidney care.
Dr. Martinez has published her findings in peer-reviewed journals including JAMA Network Open and Kidney360. She has also presented at the National Kidney Foundation Spring Clinical Meetings.
Dr. Martinez is a member of the American Society of Nephrology, the American Society of Transplantation, and the National Kidney Foundation. -
Maya Mathur
Associate Professor (Research) of Pediatrics, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsSynthesizing evidence across studies while accounting for biases
-
Helena McCombie
Chief of Staff - Office of the Chair, Medicine
Current Role at StanfordChief of Staff - Office of the Chair at Stanford University School of Medicine Department of Medicine
-
Michael V. McConnell, MD, MSEE
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMy imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.
My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health and AI to enhance heart heart in patients and populations. -
Valerie McDonald, MD, PhD
Affiliate, Department Funds
Resident in MedicineBioValerie McDonald received her MD degree from the University of Washington. During medical school, she performed research exploring correlation of a Physical Activity Vital Sign with healthcare system utilization. She is currently a resident physician in Internal Medicine at Stanford Health Care. Her career interests are patient care, research/QI, and innovation in the intersection of cardiovascular and metabolic health.
Prior to medical school, Valerie earned her PhD in environmental engineering at Michigan Technology University, studying sustainable wastewater treatment. She went on to a post-doc fellowship at the Yale Center for Biospheric Studies and Center for Green Chemistry, studying sustainability in stormwater management. She worked as a Professional Engineer for 10 years, consulting on water supply and water quality improvement projects for cities and counties throughout the Western US. -
Tracey McLaughlin
Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets
-
Bruno Medeiros
Adjunct Clinical Associate Professor, Medicine - Hematology
Current Research and Scholarly InterestsMy clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia.
-
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Jessica Lee Mega
Affiliate, Medicine - Med/Cardiovascular Medicine
BioJessica L. Mega, MD, MPH is a leader at the intersection of technology, life science, and health. She is a Cardiologist at Stanford and serves on the Advisory Board for Stanford's Center for Digital Health. She is a Co-Founder of Alphabet's Verily and former Chief Medical Officer of Google Life Sciences. She is on the Board of Directors at Boston Scientific and Danaher Corporation, as well as the Board of Advisors for Research!America and the Duke-Margolis Center for Health Policy.
As a faculty member at Harvard Medical School, a Senior Investigator with the TIMI Study Group, and a Cardiologist at Brigham and Women’s Hospital, Dr. Mega led large, international, randomized trials evaluating novel therapies and new medical technologies. She directed the TIMI Study Group’s Genomics Program, demonstrating and testing the role of CYP2C19 genetic variants on antiplatelet medications, a key pharmacogenetic finding. She has published manuscripts in the New England Journal of Medicine, Lancet, and JAMA. She served as an Advisor for the California Governor’s Precision Medicine Initiative.
Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC). -
Hector Rodrigo Mendez
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Hector Rodrigo Mendez is a Medical Geneticist from Argentina. Rodrigo completed a residency program in Medical Genetics at Centro Nacional de Genetica Medica – ANLIS (Buenos Aires, Argentina) and a Master’s program in Medical Molecular Biology at Buenos Aires University.
Rodrigo continued his scientific career at a German Genomic Start-up, working as a human geneticist and providing his experience in rare disorders, genomic data (WGS/WES/gene panels) analysis, variant interpretation, and its integration with a deep focus on genotype-phenotype correlation.
Rodrigo’s areas of expertise are rare disorders, NGS technology, Whole Genome Sequencing analysis, and ACMG interpretation guidelines, and his research aims are:
- Collection and analysis of clinical data through deep-learning phenotyping approaches.
- Multi-omic data integration to elucidate complex and rare genetic disorders.
- Drive progress in curing rare genetic diseases, particularly among critically sick infants.
At Stanford University, under the supervision of Dr. Matthew Wheeler, he is conducting his postdoctoral research studies to achieve his scientific goals.
